World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 19 October 2020
Main ID:  ISRCTN70396934
Date of registration: 29/04/2014
Prospective Registration: No
Primary sponsor: King's College London (UK)
Public title: Transcranial direct current stimulation (tDCS) in anorexia nervosa and bulimia nervosa
Scientific title: An experimental sham-controlled crossover study of prefrontal cortex transcranial direct current stimulation (tDCS) in patients with anorexia nervosa and bulimia nervosa
Date of first enrolment: 01/04/2014
Target sample size: 72
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN70396934
Study type:  Interventional
Study design:  Single-centre randomised double-blind placebo-controlled crossover study (Treatment)  
Phase:  Not Applicable
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Maria    Kekic
Address:  Section of Eating Disorders Department of Psychological Medicine Institute of Psychiatry, P059 King's College London 16 De Crespigny Park SE5 8AF London United Kingdom
Telephone: 02078480183
Email: maria.kekic@kcl.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Male or female
2. Aged over 18
3. Current DSM-V diagnosis of either:
3.1. Anorexia nervosa-restricting type
3.2. Anorexia nervosa-binge/purge type
3.3. Eating disorder not otherwise specified-anorexia type
3.4. Bulimia nervosa
3.5. Eating disorder not otherwise specified-bulimia type

Exclusion criteria:
1. Having a history of head or eye injury
2. Having a history of a neurological disease including previous seizures of any kind
3. Having a history of frequent or severe headaches
4. Having metallic implants in the head
5. Being on a dose of any psychotropic medication that has not been stable for at least 14 days prior to participation in the study
6. Taking antipsychotic medication
7. Taking anticonvulsive medication
8. Being pregnant
9. Smoking more than 15 cigarettes per day
10. Having a current major psychiatric disorder other than the eating disorder (e.g. major depressive disorder, substance use disorder, schizophrenia, or bipolar disorder) needing treatment in its own right
11. Having severe abnormalities in a blood test during the 30 days prior to participation


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Anorexia nervosa and bulimia nervosa
Mental and Behavioural Disorders
Anorexia nervosa, Bulimia nervosa
Intervention(s)

This study has three interventions:
1. Anode right/cathode left tDCS (active)
2. Anode left/cathode right tDCS (active)
3. Placebo tDCS

All participants will receive all three interventions (the order of stimulation will be randomised and counterbalanced across participants). A minimum 48-hour interval will be used between sessions to avoid any carryover effects due to stimulation. Each session will be 20 minutes long. Active tDCS will be delivered using a neuroConn® DC-STIMULATOR device at a constant current of 2 mA (with a 10-second fade in/out) using two 4 cm2 surface sponge electrodes soaked in a sterile saline solution (0.9% sodium chloride). The anode and cathode will be placed over the right (F4) and left (F3) dorsolateral prefrontal cortex (DLPFC), respectively, for intervention 1, and vice versa for intervention 2. The sites of interest will be located using the International EEG 10-20 system.

For placebo tDCS, the electrodes will be placed at the same sites as in active tDCS but the stimulation will automatically turn off after 30 seconds. Participants will therefore experience the initial itching sensation but will receive no current for the rest of the 20-minute session.
Primary Outcome(s)
The visual analogue scale (VAS) scores (0-10) obtained post-tDCS relating to hunger, urge to eat, urge to binge, urge to purge, urge to exercise, urge to restrict, feeling fat, and feeling full.
Secondary Outcome(s)

1. Post-tDCS VAS scores (0-10) relating to food ratings, stress, anxiety, tension, and mood.
2. Post-tDCS Mizes Eating Disorder Cognitions Questionnaire-Revised (MEDCQ-R) scores
3. Post-tDCS Profile of Mood States (POMS) scores
4. Post-tDCS delay discounting scores
5. Eating disorder symptoms (measured using VAS) at 24-hour follow-up
6. Blinding success
7. Tolerability of the intervention
Secondary ID(s)
N/A
Source(s) of Monetary Support
Institute of Psychiatry, King?s College London (UK)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
City Road and Hampstead National Research Ethics Service (NRES) committee;10/02/2014; ref: 14/LO/0025
Results
Results available: Yes
Date Posted:
Date Completed: 30/09/2016
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history